News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Preliminary Safety, Antitumor Activity, and ctDNA Changes with Zoldonrasib in KRAS G12D PDAC
Metastatic pancreatic cancer/onco-hema.healthbooktimes.org
Jan 29, 2025, 22:05

Preliminary Safety, Antitumor Activity, and ctDNA Changes with Zoldonrasib in KRAS G12D PDAC

Bertrand Delsuc, CEO and Founder at Biotellytics, shared on X:

“Preliminary Safety, Antitumor Activity, and ctDNA Changes with Zoldonrasib (RMC-9805), an Oral, RAS(ON) G12D-Selective, Tri-Complex Inhibitor in Patients with KRAS G12D PDAC from a Phase 1 in Advanced Solid Tumors.”

Preliminary Safety, Antitumor Activity, and ctDNA Changes with Zoldonrasib in KRAS G12D PDAC

Additional information.

Bertrand Delsuc cancer OncoDaily Oncology
Special Coverage
Science
Feb 25, 2025, 09:48
Dana-Farber Lank Center for GU Oncology Research Digest for the week of February 15 - 21
Science
Feb 25, 2025, 09:44
Laura Bukavina: 12-year outcomes of cystectomies in NMIBC
Blog
Feb 25, 2025, 09:44
How can oncologists protect their own well-being? - ESMO
Blog
Feb 25, 2025, 09:40
Yüksel Ürün: Cancer survivors face higher risk of cardiovascular disease
Blog
Feb 25, 2025, 09:39
Abhishek Shankar: Honored to have been part of the Illuminate Oncology Town Hall 2.0
Blog
Feb 25, 2025, 09:36
Melvin Chua: Pleased to see ASCOBT returning next year to the island of Singapore
Blog
Feb 25, 2025, 09:34
Lung Cancer in Women and Nonsmokers - Lung Cancer Europe
Insight
Feb 25, 2025, 09:33
Paolo Tarantino: Does Trop2 expression matter in the context of Dato-DXd treatment of mBC?
Blog
Feb 25, 2025, 09:30
Working together to make a difference - Cancer Institute NSW
Blog
Feb 25, 2025, 09:19
Biniyam Tefera Deressa: The V.O.I.C.E. initiative is coming with a transformative change in cancer care
Science
Feb 25, 2025, 09:18
Yüksel Ürün: A new mRNA cancer vaccine shows promise in pancreatic cancer
Science
Feb 25, 2025, 09:17
Lena Wirth: TLS and T-Cell Exhaustion Drive PD-1 Blockade Responce in RCC